Advanced Search: ER Positive, Her2 Negative: Endocrine

For more information about any of the clinical trials listed on this site, call 314-747-7222 or 800-600-3606 toll free or email

Select Basic Search to view clinical trials grouped by category and Advanced Search to be able to further narrow search results.



A Phase 3, Single Arm, Open Label Study of Evaluating Ovarian Suppression Following Three Month Leuprolide Acetate For Injectable Suspension (TOL2506) in Combination with Endocrine Therapy in Premenopausal Subjects with Hormone Receptor Positive (HR+), Human Epidermal Growth Factor Receptor 2 (HER2-) Negative Breast Cancer